NEVVI Medicare utilization intelligence
or

← back

Provider profile

LOCKHART, JOY NP

Nurse Practitioner · NPI 1578089751 · MONROE, LA

2
Groups
9
Codes · 2024
754
Disclosed services

LOCKHART, JOY is a Nurse Practitioner in MONROE, LA, a member of 2 medical groups, who billed 9 distinct codes to Medicare Part B in 2024.

Groups: MERCY MEDICAL HEALTH CENTER (JONESBORO, LA) · ST FRANCIS MEDICAL GROUP LLC (MONROE, LA) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

754
disclosed services
9
codes billed to Medicare Part B
Prior year · CY2023 981 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0696 Injection, ceftriaxone sodium, per 250 mg
96372 Injection of drug or substance under skin or into muscle
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1885 Injection, ketorolac tromethamine, per 15 mg
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
87804 Detection test by immunoassay with direct visual observation for influenza virus
94640 Inhalation treatment for airway obstruction or sputum production
J7030 Infusion, normal saline solution , 1000 cc
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.